BioCardia, Inc. (Nasdaq: BCDA) announced that the FDA has confirmed and finalized meeting minutes from a pre-submission meeting regarding the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE